source
- Sionna Therapeutics cuts 46% of staff after cystic fibrosis trial missSionna Therapeutics announced it will lay off roughly half of its employees as it reassesses its strategy following a recent setback in its cystic fibrosis program. The company’s lead candidate, S…
- Legend Biotech appoints former Novartis executive as CEO while Vera pursues full approval for kidney drugLegend Biotech announced that Ingrid Zhang, a former Novartis executive, will take over as chief executive officer, replacing Ying Huang who stepped down in July. Vera reported that its recently l…